Synthesis, characterization and evaluation of cytotoxicity of new aminophosphonic acid diesters in human leukemia cells

Letters in Drug Design and Discovery

Volumn 7, Issue 4, 2010, Pages 250-259

  Balakrishna, Avula ^a   Chiruvella, Kishore K ^b   Reddy, Mudumala V N ^a   Reddy, Rajesh ^b   Nayak, Sandip K ^c   Raghavan, Sathees C ^a,b   Reddy, Cirandur S ^a  

^a SRI VENKATESWARA UNIVERSITY   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Aminophosphonate; Cem cell; Cytotoxicity; Fluorine; Leukmia; Synthesis; TMG

Indexed keywords

DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(2' METHOXYPHENYL) METHYL PHOSPHONATE; DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(2',4' DICHLOROPHENYL) METHYL PHOSPHONATE; DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(3' NITROPHENYL) METHYL PHOSPHONATE; DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(4' CHLOROPHENYL) METHYL PHOSPHONATE; DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(4' FLUORO PHENYL) METHYL PHOSPHONATE; DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(4' HYDROXYPHENYL) METHYL PHOSPHONATE; DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(4' METHOXYPHENYL) METHYL PHOSPHONATE; DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(4' METHYLPHENYL) METHYL PHOSPHONATE; DIMETHYL (3 CHLORO 4 FLUOROPHENYLAMINO)(FURYL) METHYL PHOSPHONATE; DIMETHYL (3-CHLORO 4 FLUOROPHENYLAMINO)(5' BROMO 2' HYDROXYPHENYL) METHYL PHOSPHONATE; ESTER DERIVATIVE; FLUOROAMINOPHOSPHATE; NITROBLUE TETRAZOLIUM; PHOSPHORAMIDIC ACID; TRYPAN BLUE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYST; CELL PROLIFERATION; CELL VIABILITY; CYTOTOXICITY; DRUG DETERMINATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFRARED SPECTROSCOPY; LEUKEMIA CELL; MASS SPECTROMETRY; ONE POT SYNTHESIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; T LYMPHOCYTE;

EID: 77949682110     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018010790945841     Document Type: Article

References (28)

1. Bieker, R.; Lerchenmuffer, C.; Wehmeyer, J.; Serve, H.L.; Mesters, R.M.; Buchner, T.; Berdel, W.E. Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia. Oncol. Rep., 2003, 10, 915-920.
2. Collins, S.J. The HL-60 promyelotic leukemia cell line: proliferation, differentiation and cellular oncogene expression. Blood, 1987, 70(5), 1233-1244.
3. Sach, S.L. The control of haematopoiesis and leukemia: from basic biology to the clinic. Proc. Natl. Acad. Sci. USA, 1996, 93(10), 4742-4729.
4. Bruserud, O.; Gjertsen, B.T. New strategies for the treatment of acute myelogenous leukemia: different induction-present use and future possibilities. Stem Cells, 2000, 18(3), 157-165.
5. Kavitha, C.V.; Rangappa, K. S.; Sathees, C.R. Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells. Biochem. Pharmacol., 2009, 77(3), 348-363.
6. Noyori, R. Asymmetric Catalysis in Organic Synthesis: John Wiley & Sons: New York, 1994.
7. Broch, R.F.; Canute, G.W. Synthesis and antitumor properties of activated cyclophosphamide analogs. J. Med. Chem., 1991, 34(10), 3044-3052.
8. Van Maanena, M.J.; Smeets, C.J.M.; Beijnen, J.H. Chemistry, Phrmacology and pharmacokinetics of N,N′, N″-riethylenethiophospharamide. Cancer Treat. Rev., 2000, 26(4), 257-268.
9. Kafarski, P.; Lejczak, B. Aminophosphonic acids of potential Importance. Curr. Med. Chem. Anticancer Agents, 2001, 1, 301-312.
10. Atherton, F.R.; Hassall, C.H.; Lambert, R.W. Synthesis and structure activity relationships of antibacterial phosphonopeptides incorporating (1-aminomethyl) phosphonic and (amino methyl) phosphonic acids. J. Med. Chem., 1986, 29(1), 29-40.
11. Oleksyszyn, J. In: V.P. Kukhar, H.R. Hudson Eds., Aminophosphonic and Aminophosphonic Acids Chemistry and Biological Activity, John Wiley & Sons, Chichester, 2000, p. 537.
12. Bird, J.; De Mello, R.C.; Harper, G.P.; Hunter, D.J.; Karran, E.H.; Markewll, R.E.; Miles-Williams, A.J.; Rahman, S.S.; Ward, R.W. Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase. J. Med. Chem., 1994, 37(1), 158-169.
13. Mizrahi, D.M.; Waner, T.; Segall, Y. α-Amino acid derivatived bisphosphonates. Synthesis and anti-resorptive activity. Phosphorus Sulfur Silicon Relat. Elem., 2001, 173, 1-25.
14. Green, J.R. Med. Klin. Anti-tumor potential of bisphopshonates. 2000, 95(Suppl. II), 23-28.
15. Dormehl, I.C.; Louw, W.K.A.; Milner, R.J.; Kilian, E.; Schneeweiss, F.H.A. Biodistribution and pharmacokinetics of variously sized molecular radiolabelled polyethleneinoaminomethyl phosphonic acid as a selective bone seeker for therapy in the normal primate model. Arzneim-Forsch, 2001, 51(3), 258-263.
16. Budzisz, E.; Brzezinska, E.; Krajewsk, U.; Rozalski, M. Cytotoxic effects, alkyalating properties and molecular modeling of coumarin derivatives and their phopshonic analogues. Eur. J. Med. Chem., 2003, 38(6), 597-603.
17. Kostka, K.; Pastuszko, S.; Porada, M. Investigation in the chromone series. Part XX. Chromone -3- phosphonic acids and esters. Phosphorus Sulfur Silicon, 1992, 71, 67-74.
18. Kramata, P.; Downey, K.M. 9-(2-phosphonylmethoxyethyl) derivatives of purine nucleotide analogs: A comparison of their metabolism and interaction with cellular DNA synthesis. Mol. Pharmacol., 1999, 56, 1262-1270.
19. Lavielle, G.; Hautefaye, P.; Schaeffer, C.; Boutin, J.A.; Claude, A.; Cudennec; Pierr, A. New α-amino phosphonic acid derivatives of vinblastine: chemistry and antitumor activity. J. Med. Chem., 1991, 34, 1998-2003.
20. Zefirov, N.S.; Matveeva, E.D. Catalytic Kabachnik-Fields reaction: new horizons for old reaction. Arkivoc, 2008, (i), 1-8.
21. Moonen, K.; Stevens, C.V. one-pot synthesis of N-chloro acetyl 1-aminoalkyl phosphonates - precursors of 4- phosphono -β-Lactams. Synthesis, 2005, 20, 3603-3612.
22. Qian, C.; Huang, T. One pot synthesis of α-amino phosphonates from aldehydes using Lanthanide triflate using as catalyst. J. Org. Chem., 1998, 63, 4125-4128.
23. Baoan, S.; Yang, S.; Yanping, H.; Zhang, G.; Linhong, J.; Deyu, H. Synthesis and bioactivity of fluorine compounds containing isoxazolylamino and phosphonate groups. J. Fluorine Chem., 2005, 126, 1419-1424.
24. Kiran, Y.B.; Reddy, C.D.; Gunasekar, D.; Suresh, R.C.; Annette, L.; Luiz, B.C.A. Synthesis and anticancer activity of new class of bisphosphonates/ phosphanamidates. Eur. J. Med. Chem., 2008, 43(4), 885-892.
25. th ed. Goodman & Gilman's New York, 2006, p. 41.
26. Begue, J.P.; Hoboken, N.J.; Delpon, D.B. Bioorganic and Medicinal Chemistry of Fluorine John Wiley and Sons, Inc. 2008.
27. Thimmegowda, N.R.; Kavitha, C.V.; Kishore, K.C.; Omana, J.; Rangappa, K. S.; Sathees, C.R. Synthesis and biological evaluation of novel 1-(4- mehoxyphenethyl)-1H-benzimidazole-5- 4 carbpxylic acid derivatives and their precursors as antileukemic agents. Bioorg. Med. Chem. Lett., 2009, 19, 4594-4600.
28. Kishore, K.; Chiruvella, V.K.; Choudhary, B.; Mridula, N.; Rama, G.G.; Sathees, C.R. Methyl angolensate, a natural tetranortriterpenoid induces intrinsic apoptotic pathway in leukemic cells. FEBS Lett., 2008, 582(29), 4066-4076.